A Win For Zhengye Biotechnology Holding Limited
Fri, Oct 09, 2026 at 07:40 PM
Zhengye Biotechnology Holding Limited (ZYBT:NASDAQ) rocketted at $1.73, representing a gain of 50.4%. On Fri, Oct 09, 2026, ZYBT:NASDAQ hit a New 2-Week High of $1.73. The stock got featured on our News Catalysts scanner on Tue, Sep 15, 2026 at 03:34 AM in the 'BIOTECH' category. From Fri, Sep 25, 2026, the stock recorded 30.00% Up Days and 54.55% Green Days
The stock spiked on Fri, Oct 09, 2026 at $2.89 with a volume of 28M+.
About Zhengye Biotechnology Holding Limited (ZYBT:NASDAQ)
Zhengye Biotechnology Holding, through its operating entity, focus on the research, development, manufacturing and sales of veterinary vaccines, with an emphasis on vaccines for livestock.
Top 10 Gainers:
- WF Holding Limited (WFF:NASDAQ), 499.51%
- Jianzhi Education Technology Group Company Limited (JZ:NASDAQ), 53.55%
- Zhengye Biotechnology Holding Limited (ZYBT:NASDAQ), 50.45%
- Veea Inc. (VEEA:NASDAQ), 47.29%
- Quetta Acquisition Corporation (QETA:NASDAQ), 41.47%
- PDS Biotechnology Corporation (PDSB:NASDAQ), 35.29%
- OFA Group (OFAL:NASDAQ), 33.59%
- NEXGEL, Inc. (NXGL:NASDAQ), 33.53%
- Quantum-Si incorporated (QSI:NASDAQ), 25.41%
- Concord Medical Services Holdings Limited (CCM:NYSE), 25.16%